Takefumi Satoh

4.6k total citations
157 papers, 3.6k citations indexed

About

Takefumi Satoh is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Radiation. According to data from OpenAlex, Takefumi Satoh has authored 157 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 99 papers in Pulmonary and Respiratory Medicine, 33 papers in Oncology and 28 papers in Radiation. Recurrent topics in Takefumi Satoh's work include Prostate Cancer Treatment and Research (73 papers), Prostate Cancer Diagnosis and Treatment (69 papers) and Advanced Radiotherapy Techniques (28 papers). Takefumi Satoh is often cited by papers focused on Prostate Cancer Treatment and Research (73 papers), Prostate Cancer Diagnosis and Treatment (69 papers) and Advanced Radiotherapy Techniques (28 papers). Takefumi Satoh collaborates with scholars based in Japan, United States and United Kingdom. Takefumi Satoh's co-authors include Shiro Baba, Timothy C. Thompson, Τοyoaki Uchida, Kazumasa Matsumoto, Terry L. Timme, Akira Irie, Masatsugu Iwamura, Ken‐ichi Tabata, Guang Yang and Toru Hyodo and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Scientific Reports.

In The Last Decade

Takefumi Satoh

153 papers receiving 3.5k citations

Peers

Countries citing papers authored by Takefumi Satoh

Since Specialization

Citations

This map shows the geographic impact of Takefumi Satoh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takefumi Satoh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takefumi Satoh more than expected).

Fields of papers citing papers by Takefumi Satoh

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Takefumi Satoh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takefumi Satoh. The network helps show where Takefumi Satoh may publish in the future.

Co-authorship network of co-authors of Takefumi Satoh

This figure shows the co-authorship network connecting the top 25 collaborators of Takefumi Satoh. A scholar is included among the top collaborators of Takefumi Satoh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takefumi Satoh. Takefumi Satoh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A phase II trial of stereotactic body radiotherapy in 4 fractions for patients with localized prostate cancer 2022 ·Radiation Oncology ·(unknown), Hideyasu Tsumura, Takefumi Satoh, Ken‐ichi Tabata, (unknown), (unknown), M Nakano, Masatsugu Iwamura, Hiromichi Ishiyama	6
2	Unmet needs in non-metastatic castration-resistant prostate cancer from the Japanese patient perspective: a discrete choice experiment 2021 ·BMJ Open ·Hiroji Uemura, Hisashi Matsushima, Akira Yokomizo, Kazuki Kobayashi, Gaku Arai, Takefumi Satoh, (unknown), Yirong Chen, (unknown), Dianne Athene Ledesma	1
3	60MO Gut microbiota and efficacy of immune-checkpoint inhibitors (ICIs) in patients (pts) with advanced solid tumor: SCRUM-Japan MONSTAR-SCREEN 2021 ·Annals of Oncology ·Jun Wada, Ryo Yamashita, (unknown), Takao Fujisawa, A. Yoshikawa, Yuichi Nakamura, Hiroki Taniguchi, Shigenori Kadowaki, (unknown), Tetsuya Kodama, Kazuaki Kato, Takefumi Satoh, Yoshito Komatsu, Masaki Shiota, Hisateru Yasui, (unknown), Tateki Yoshino	0
4	Perioperative Search for Circulating Tumor Cells in Patients Undergoing Prostate Brachytherapy for Clinically Nonmetastatic Prostate Cancer 2017 ·International Journal of Molecular Sciences ·Hideyasu Tsumura, Takefumi Satoh, Hiromichi Ishiyama, Ken‐ichi Tabata, (unknown), (unknown), Masaki Nakamura, (unknown), Kazushige Hayakawa, Masatsugu Iwamura	26
5	Abiraterone Followed by Enzalutamide Versus Enzalutamide Followed by Abiraterone in Chemotherapy-naive Patients With Metastatic Castration-resistant Prostate Cancer 2017 ·Clinical Genitourinary Cancer ·Nobuaki Matsubara, Yoko Yamada, Ken‐ichi Tabata, Takefumi Satoh, Naoto Kamiya, Hiroyoshi Suzuki, Takashi Kawahara, Hiroji Uemura, Akihiro Yano, Satoru Kawakami, (unknown), Satoshi Fukasawa	29
6	Hospital Resource Use in Metastatic Castration Resistant Prostate Cancer (MCRPC) in National University Hospitals in Japan 2017 ·Value in Health ·Takefumi Satoh, (unknown), (unknown)	1
7	A multicenter retrospective analysis of sequential treatment of abiraterone acetate followed by docetaxel in Japanese patients with metastatic castration-resistant prostate cancer 2015 ·Japanese Journal of Clinical Oncology ·(unknown), Nobuaki Matsubara, Itsuhiro Takizawa, Tsutomu Nishiyama, Ken‐ichi Tabata, Takefumi Satoh, Naoto Kamiya, Hiroyoshi Suzuki, Takashi Kawahara, Hiroji Uemura	8
8	Tumor growth and metastasis suppression by Glipr1 gene-modified macrophages in a metastatic prostate cancer model 2011 ·Gene Therapy ·Ken-ichi Tabata, Shinji Kurosaka, Mayumi Watanabe, Kohei Edamura, Takefumi Satoh, Guang Yang, (unknown), Jing Wang, Alexei A. Goltsov, Daniel Floryk, Timothy C. Thompson	9
9	The Radiotherapy with Methotrexate, Vinblastine, Doxorubicin, and Cisplatin Treatment Is an Effective Therapeutic Option in Patients with Advanced or Metastatic Bladder Cancer 2011 ·Journal of Radiation Research ·Masaomi Ikeda, Kazumasa Matsumoto, Yuzuru Niibe, Takefumi Satoh, Tetsuo Fujita, Masatsugu Iwamura, Hiromichi Ishiyama, (unknown), Kazushige Hayakawa, Shiro Baba	9
10	Prevalence of Fluoroquinolone-resistant Escherichia coli Before and Incidence of Acute Bacterial Prostatitis After Prostate Biopsy 2011 ·Urology ·(unknown), Takefumi Satoh, Ken‐ichi Tabata, Masaki Kimura, Hideyasu Tsumura, Shinji Kurosaka, Kazumasa Matsumoto, Tetsuo Fujita, Masatsugu Iwamura, Shiro Baba	39
11	Differences between intraoperative ultrasound-based dosimetry and postoperative computed tomography-based dosimetry for permanent interstitial prostate brachytherapy 2010 ·Brachytherapy ·Hiromichi Ishiyama, Ryuji Nakamura, Takefumi Satoh, Susumu Tanji, (unknown), Shiro Baba, Kazushige Hayakawa	12
12	Cost comparison of curative therapies for localized prostate cancer in Japan: a single-institution experience 2009 ·Japanese Journal of Radiology ·Takefumi Satoh, Hiromichi Ishiyama, Kazumasa Matsumoto, Ken‐ichi Tabata, (unknown), Masatsugu Iwamura, Masaki Kimura, (unknown), Hideyuki Yamashita, Daisuke Matsuda, (unknown), Yuzuru Niibe, (unknown), Kazushige Hayakawa, Shiro Baba	3
13	Therapeutic effects of gelatin matrix-embedded IL-12 gene-modified macrophages in a mouse model of residual prostate cancer 2008 ·Prostate Cancer and Prostatic Diseases ·Ken-ichi Tabata, Mayumi Watanabe, Koji Naruishi, Kohei Edamura, Takefumi Satoh, Guang Yang, (unknown), (unknown), Alexei A. Goltsov, Daniel Floryk, (unknown), Dov Kadmon, Timothy C. Thompson	8
14	Adenoviral vector-mediated RTVP-1 gene-modified tumor cell-based vaccine suppresses the development of experimental prostate cancer 2006 ·Cancer Gene Therapy ·Koji Naruishi, T L Timme, Nobuyuki Kusaka, Tetsuo Fujita, Guang Yang, Alexei A. Goltsov, Takefumi Satoh, (unknown), (unknown), (unknown), Tongyi Men, Mayumi Watanabe, Ken-ichi Tabata, Timothy C. Thompson	20
15	High-dose rate iridium-192 brachytherapy boost to external beam radiation therapy for prostate cancer in Japanese men 2005 ·Takefumi Satoh, (unknown), Tetsuo Fujita, Hiromichi Ishiyama, (unknown), (unknown), (unknown), (unknown), Kazumasa Matsumoto, Akira Irie, Takashi Arakawa, Shin Egawa, Kazushige Hayakawa, Shiro Baba	2
16	Cancer core distribution in patients diagnosed by extended transperineal prostate biopsy 2005 ·Urology ·Takefumi Satoh, Kazumasa Matsumoto, Tetsuo Fujita, Ken‐ichi Tabata, (unknown), (unknown), Takashi Arakawa, Akira Irie, Shin Egawa, Shiro Baba	52
17	In Situ Gene Therapy for Prostate Cancer 2005 ·Current Gene Therapy ·Takefumi Satoh, Akira Irie, Shinichi Egawa, Shiro Baba	22
18	Disruption of the Caveolin-1 Gene Impairs Renal Calcium Reabsorption and Leads to Hypercalciuria and Urolithiasis 2003 ·American Journal Of Pathology ·Guangwen Cao, Guang Yang, Terry L. Timme, Takashi Saika, Luan D. Truong, Takefumi Satoh, Alexei A. Goltsov, Sang Hee Park, Taoyan Men, Nobuyuki Kusaka, Weihua Tian, Chengzhen Ren, Hongyu Wang, Dov Kadmon, Wei Cai, A. Craig Chinault, Timothy B. Boone, Allan Bradley, Timothy C. Thompson	73
19	Antitumor Effect of bcl-2 Antisense Phosphorothioate Oligodeoxynucleotides on Human Renal-Cell Carcinoma Cells in Vitro and in Mice 2001 ·PubMed ·Τοyoaki Uchida, Jiangping Gao, Chunxi Wang, Takefumi Satoh, (unknown), Masatoshi Muramoto, Toru Hyodo, Akira Irie, Tohru Akahoshi, Shi-Xu Jiang, Toru Kameya, Shiro Baba	14
20	Improved predictability of extracapsular extension and seminal vesicle involvement based on clinical and biopsy findings in prostate cancer in Japanese men 1998 ·Urology ·Shin Egawa, K Suyama, Kazumasa Matsumoto, Takefumi Satoh, Τοyoaki Uchida, Sadahito Kuwao, Ken Koshiba	54

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact